| Cyclodextrin-based nanosponges encapsulating camptothecin: Physicochemical characterization, stability and cytotoxicity S Swaminathan, L Pastero, L Serpe, F Trotta, P Vavia, D Aquilano, ... European journal of pharmaceutics and biopharmaceutics 74 (2), 193-201, 2010 | 438 | 2010 |
| Formulation of betacyclodextrin based nanosponges of itraconazole S Swaminathan, PR Vavia, F Trotta, S Torne Journal of inclusion phenomena and macrocyclic chemistry 57, 89-94, 2007 | 251 | 2007 |
| Encapsulation of Acyclovir in new carboxylated cyclodextrin-based nanosponges improves the agent's antiviral efficacy D Lembo, S Swaminathan, M Donalisio, A Civra, L Pastero, D Aquilano, ... International journal of pharmaceutics 443 (1-2), 262-272, 2013 | 224 | 2013 |
| Lipid nanoparticles for intranasal administration: application to nose-to-brain delivery L Battaglia, PP Panciani, E Muntoni, MT Capucchio, E Biasibetti, ... Expert opinion on drug delivery 15 (4), 369-378, 2018 | 178 | 2018 |
| Cyclodextrin‐based nanosponges: a versatile platform for cancer nanotherapeutics development S Swaminathan, R Cavalli, F Trotta Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 8 (4 …, 2016 | 163 | 2016 |
| In vitro release modulation and conformational stabilization of a model protein using swellable polyamidoamine nanosponges of β-cyclodextrin S Swaminathan, R Cavalli, F Trotta, P Ferruti, E Ranucci, I Gerges, ... Journal of inclusion phenomena and macrocyclic chemistry 68, 183-191, 2010 | 132 | 2010 |
| Nanosponges encapsulating dexamethasone for ocular delivery: formulation design, physicochemical characterization, safety and corneal permeability assessment S Swaminathan, PR Vavia, F Trotta, R Cavalli Journal of biomedical nanotechnology 9 (6), 998-1007, 2013 | 105 | 2013 |
| Structural evidence of differential forms of nanosponges of beta-cyclodextrin and its effect on solubilization of a model drug S Swaminathan, PR Vavia, F Trotta, R Cavalli, S Tumbiolo, L Bertinetti, ... Journal of Inclusion Phenomena and Macrocyclic Chemistry, 1-11, 2012 | 98 | 2012 |
| Applications of nanosponges in drug delivery PR Vavia, S Swaminathan, F Trotta, R Cavalli Proceedings XIII International Cyclodextrin Symposium, 14-17, 2006 | 33 | 2006 |
| Chemistry and art of developing lipid nanoparticles for biologics delivery: focus on development and scale-up R John, J Monpara, S Swaminathan, R Kalhapure Pharmaceutics 16 (1), 131, 2024 | 24 | 2024 |
| Genetic Modulation of the Iris Transillumination Defect: A Systems Genetics Analysis using the Expanded Family of BXD Glaucoma Strains S Swaminathan, H Lu, RW Williams, L Lu, MM Jablonski Pigment Cell & Melanoma Research, 2013 | 23 | 2013 |
| DRUG DELIVERY| Bioavailability-Nanosponge-Aided Drug Delivery: A Closer Look S Swaminathan, S Darandale, PR Vavia | 21 | 2012 |
| Cyclodextrin-based nanohydrogels containing polyamidoamine units: a new dexamethasone delivery system for inflammatory diseases M Argenziano, C Dianzani, B Ferrara, S Swaminathan, A Manfredi, ... Gels 3 (2), 22, 2017 | 19 | 2017 |
| Proline-catalysed asymmetric annelations: a novel observation N Ramamurthi, S Swaminathan Indian Journal of Chemistry 29 (5), 401-404, 1990 | 18 | 1990 |
| Soluble Itraconazole in Tablet Form Using Disordered Drug Delivery Approach: Critical Scale-up Considerations and Bio-equivalence Studies S Swaminathan, M Sangwai, S Wawdhane, P Vavia AAPS PharmSciTech, doi10.1208/s12249-012-991, 2013 | 17 | 2013 |
| Release modulation and conformational stabilization of a model protein by use of swellable nanosponges of betacyclodextrin S Swaminathan, P Vavia, F Trotta, R Cavalli, P Ferruti, E Ranucci, ... First European Cyclodextrin conference, Aalborg, Denmark, 2009 | 13 | 2009 |
| Cyclodextrin nanosponges S Swaminathan, F Trotta Nanosponges: Synthesis and Applications, 27-57, 2019 | 8 | 2019 |
| Novel functionalized nanosponges: synthesis, characterization. Safety assessment, cytotoxicity testing and interaction studies F Trotta, R Cavalli, S Swaminathan, C Sarzanini, P Vavia Proceedings of the 14th International Cyclodextrin Symposium, Kyoto, 338-342, 2008 | 8 | 2008 |
| "Studies on novel dosage forms." S Swaminathan " Masters of pharmaceutical Sciences Dissertation submitted to the …, 2006 | 7 | 2006 |
| Novel Endogenous Glycan Therapy for Retinal Diseases: Safety, In Vitro Stability, Ocular Pharmacokinetic Modeling, and Biodistribution S Swaminathan, H Li, M Palamoor, WT Luchsinger de Obarrio, ... AAPS Journal, 2014 | 4 | 2014 |
Dora Babu MadhuraPharmacokineticist, PK/PD optmization, Biopharmaceutics, UTHSCVerified email at uthsc.edu